TECON BIOLOGY Co.LTD (SHE:002100)
China flag China · Delayed Price · Currency is CNY
7.99
-0.04 (-0.50%)
Sep 14, 2026, 3:04 PM CST

TECON BIOLOGY Co.LTD Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
2,5352,0813,1022,8223,3203,424
Trading Asset Securities
361.95349.975.520.47650.94-
Cash & Short-Term Investments
2,8972,4313,1072,8223,9703,424
Cash Growth
-3.73%-21.78%10.11%-28.92%15.96%64.03%
Accounts Receivable
565.65450.22534.08444.28401.82314.58
Other Receivables
177.05274.9396.56425.39464.03437.5
Receivables
742.7728.61943.13889.67885.44771.88
Inventory
4,3235,5654,5944,5546,0425,251
Prepaid Expenses
-----5.37
Other Current Assets
997.571,2251,204695.11,4981,160
Total Current Assets
8,9609,9509,8488,96112,39610,612
Property, Plant & Equipment
8,9406,7156,9757,0936,4536,081
Long-Term Investments
17.8916.5233.2936.11105.45108.07
Goodwill
719.76165.82165.82178.4822.2422.24
Other Intangible Assets
361.9363.78377.17360.84268.4272.11
Long-Term Deferred Tax Assets
126.72112.2599.1472.1839.5416.06
Long-Term Deferred Charges
29.092926.4831.0530.8326.17
Other Long-Term Assets
24.6739.1738.2219.3446.91.28
Total Assets
19,18017,39117,56316,75219,36217,139

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
784.12601.58611.86697.12611.11465.23
Accrued Expenses
176.47257.29364.43411.89405.67436.52
Short-Term Debt
2,1513,1143,2333,3193,2154,039
Current Portion of Long-Term Debt
899.81996.28739.81,366624.37676.7
Current Portion of Leases
-69.75126.1122.77102.3164.85
Current Income Taxes Payable
12.096.4511.6816.8311.238.27
Current Unearned Revenue
735.88806.3669.11444.63476.32686.52
Other Current Liabilities
2,097643.55738.56708.94762.53594.67
Total Current Liabilities
6,8576,4956,4957,0876,2086,971
Long-Term Debt
3,1401,8762,0571,2253,1332,059
Long-Term Leases
342.92313.04322.12362.93302.53294.58
Long-Term Unearned Revenue
252.89152.94144.58143.2987.5181.02
Long-Term Deferred Tax Liabilities
13.8718.0817.6218.131.450.75
Other Long-Term Liabilities
50.090.096.42---
Total Liabilities
10,6568,8549,0438,8379,7339,406

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
1,3651,3651,3651,3651,3541,354
Additional Paid-In Capital
3,9453,9453,9423,9423,8423,303
Retained Earnings
1,0161,5671,6571,0522,7132,447
Comprehensive Income & Other
16.3563.6551.0651.125.03-5.4
Total Common Equity
6,3426,9417,0166,4117,9157,098
Minority Interest
2,1821,5951,5041,5041,715634.88
Shareholders' Equity
8,5248,5378,5207,9159,6307,733
Total Liabilities & Equity
19,18017,39117,56316,75219,36217,139

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
6,5336,3686,4796,3967,3777,133
Net Cash (Debt)
-3,637-3,938-3,371-3,574-3,406-3,709
Net Cash Growth
------
Net Cash Per Share
-2.57-2.80-2.45-2.65-2.55-3.38
Filing Date Shares Outstanding
1,3981,3651,3651,3651,3541,354
Total Common Shares Outstanding
1,3981,3651,3651,3651,3541,354
Working Capital
2,1033,4553,3531,8746,1883,641
Book Value Per Share
4.535.085.144.705.845.24
Tangible Book Value
5,2606,4126,4735,8717,6256,803
Tangible Book Value Per Share
3.764.704.744.305.635.03
Buildings
-5,3695,2374,6644,1833,541
Machinery
-4,1463,9923,4993,2062,626
Construction In Progress
-255.43233.09814.7425.14894.54